• Mashup Score: 8

    Welcome to the September 2023 Sexual Health & HIV Policy EUROBulletin. In the feature in this edition, we talk to Dr Esteban Martínez, president of the European AIDS Clinical Society (EACS). The European AIDS Conference is being held in Poland next month and we spoke to Esteban about what to expect from the conference, the importance of responding to the HIV epidemic in eastern Europe and the role of EACS in supporting clinicians and people living with HIV from Ukraine.

    Tweet Tweets with this article
    • Other items to look out for include: reports from the European Centre for Disease Prevention and Control (ECDC) on progress towards HIV targets; a new website for queer migrants moving into or around Europe; and reports of multidrug-resistant shigella. https://t.co/Pqr4RiP5fY https://t.co/LcuH5KCW11

    • The September 2023 Sexual Health & HIV Policy EUROBulletin is available to read online. In this edition's feature, we spoke to Dr Esteban Martínez, @EACSociety president, about what to expect from #EACS2023, starting today in Warsaw. https://t.co/Pqr4RiP5fY https://t.co/L15w1GWArL

  • Mashup Score: 4
    Cancer and HIV - 5 month(s) ago

    Cancers are diseases of cells in the body. Rates of some, but not all, cancers are higher in people living with HIV than other people.

    Tweet Tweets with this article
    • Rates of some cancers are higher in people with HIV than other people. In our updated page on cancer & HIV, read about the lifestyle changes that can reduce your risk of developing cancer, cancer in people with HIV, symptoms, diagnosis, & treatment. https://t.co/e4CQWBfKEz

  • Mashup Score: 0

    In some cases, HIV can bypass the barrier that encases the brain and cerebrospinal fluid which can contribute to brain inflammation and neurocognitive symptoms. However, diagnosing this viral ‘escape’ into cerebrospinal fluid is challenging due to its anatomical inaccessibility. Swiss researchers found that the presence of the virus did not clearly correlate with symptoms.

    Tweet Tweets with this article
    • HIV in the brain – does it correlate with neurocognitive symptoms? https://t.co/LYpPkVisb0 https://t.co/gFXs4WGKoq

  • Mashup Score: 2

    Making the commonly prescribed antiretroviral regimen of tenofovir, lamivudine and dolutegravir available in the community as post-exposure prophylaxis after condomless sex, without a prescription, would reduce HIV acquisition by 31% over 20 years in African countries, according to a modelling study published in Lancet Global Health.

    Tweet Tweets with this article
    • Making PEP available in the community could reduce new HIV cases in Africa by 31% https://t.co/kBZwhYSXz8 https://t.co/J4JvEWOQUp

  • Mashup Score: 1

    Join team aidsmap on Saturday 25 November 2023 for the World AIDS Day RED RUN in Victoria Park, east London. This annual 5k or 10k run (or walk!) is about fighting HIV stigma and raising awareness and vital funds to support HIV charities across the UK. All participants receive a RED RUN t-shirt and tote bag, a finisher’s medal and free coffee (there’s also chip timing for those who are keen).

    Tweet Tweets with this article
    • Join team aidsmap on Saturday 25 Nov for World AIDS Day RED RUN! Walk or run 5k or 10k to support our life-changing work, and we’ll send you a Fight HIV Stigma bandana for you or a four-legged friend (yes dogs are welcome too!)👉 Register today: https://t.co/MQuIJcjQ5S #RedRunLDN https://t.co/w4I3DBrel8

  • Mashup Score: 4

    A new TV advert highlights how HIV positive people can live healthy lives thanks to medical advances.

    Tweet Tweets with this article
    • 📺 For the first time in 40 years, a TV advert on #HIV will hit the screen in #Scotland to promote awareness & understanding of HIV and tackle the #stigma surrounding it. The campaign, produced by the @THTorguk, is set to air today. Read + in @BBCNews: https://t.co/sWD42UMJyj

  • Mashup Score: 1

    Home > HIVR4P 2024, the 5th HIV Research for Prevention Conference HIVR4P 2024, the 5th HIV Research for Prevention Conference, will take place in Lima, Peru, and virtually from 6 to 10 October 2024 and is expected to bring together around 1,500 participants. The HIV Research for Prevention Conference is the only global scientific conference focused exclusively on the challenging and fast-growing field of HIV prevention research. This conference fosters interdisciplinary knowledge exchange on HIV vaccines,

    Tweet Tweets with this article
    • 📣 The final session of the #HIVR4P virtual symposia series is happening today at 19:00 CEST! Leading experts will share insights into the future of #bNAbs. You can still join today's symposia by registering now for free! https://t.co/kdCxifeGXn https://t.co/3Md7MCwEOS

  • Mashup Score: 9

    A very few people with HIV can control the virus without treatment; some of them can suppress the virus from the very beginning, while others achieve control with the help of initial antiretroviral therapy. This is the case of a man who has been effectively controlling the virus for 23 years after a short course of treatment. A team of Dutch researchers found that the virus is still present and intact in his cells and blood. They tried to explore the mechanisms by which he could maintain this control and described their findings in the journal AIDS.  

    Tweet Tweets with this article
    • A man has maintained control over #HIV for 23 years after only a short course of treatment. Researchers in the #Netherlands studied his unique case & found some insights into how his immune system controls the virus. Learn + in the @aidsmap article: https://t.co/LhauUEOzcN

  • Mashup Score: 1

    A very few people with HIV can control the virus without treatment; some of them can suppress the virus from the very beginning, while others achieve control with the help of initial antiretroviral therapy. This is the case of a man who has been effectively controlling the virus for 23 years after a short course of treatment. A team of Dutch researchers found that the virus is still present and intact in his cells and blood. They tried to explore the mechanisms by which he could maintain this control and described their findings in the journal AIDS.  

    Tweet Tweets with this article
    • Man controls HIV for 23 years after a short course of treatment https://t.co/ruxRrYqbSC https://t.co/SUvVkNb0q6